Clinical retrospective analysis of peri-implant oral malignancies

Seo, Mi Hyun; Eo, Mi Young; Park, Min Woo; Myoung, Hoon; Lee, Jong Ho; Kim, Soung Min

doi:10.1186/s40729-024-00527-0

International Journal of Implant Dentistry

Table 1 Demographic and clinical data of 21 patients with PIOM in this study

From: Clinical retrospective analysis of peri-implant oral malignancies

No.	Sex	Age	OH	S/A	PMH	Site	IS	Time to Ca (weeks)	PC	HPV	CA	Op. date	Dx	HF	pStage	BI	BG	ImpS	R	PM	OccP	OccPM
1	M	44	Moderate	–	n/s	Lower	45,46,47	48	–	n.c	E	2008-02-21	SCC	Well	IV	Pr	-	TiO₂	Sc	Gold	P	PFM
2	F	48	Poor	–	HTN	Lower	43,44	9	Previous SCC	n.c	E	2008-06-23	SCC	Poor	IV	Pr	Auto	SLA	Sc	Gold	None	–
3	M	54	Moderate	S + A	n/s	Lower	46,47	10	–	n.c	E	2008-12-22	SCC	Moderate	IV	Pr	Auto	RBM	Sc	Gold	P/implant	PFM
4	F	56	Moderate	–	Metal allergy	Lower	45,46,47,48	41	–	n.c	EU	2009-02-16	SCC	Well	IV	Pr	-	SLA	Sc,C	Gold/Sc,PFM/C	None	–
5	M	72	Poor	–	LC	Lower	32,33,35,36,37	14	–	n.c	EU	2009-10-22	SCC	Well	IV	Pr	-	RBM	C	PFM	P	PFM
6	M	61	Moderate	–	n/s	Lower	34,35,36,37	90	–	n.c	U	2010-02-22	SCC	Well	IV	Pr	-	TPS	C,Sc	PFM/C,Gold/Sc	P/implant	Gold
7	F	69	Moderate	–	Osteoporosis	Upper	13,14,15,16,17	24	–	n.c	EU	2010-08-05	SCC	Well	IV	Pr	-	HA blast and acid wash	C	PFM	P/implant	PFM
8	F	68	Good	–	Aspirin	Upper	16,17	–	–	n.c	U	2011-01-06	SCC	Moderate	IV	Pr	-	TiO₂	C	PFM	P/implant	PFM
9	M	61	Moderate	S + A	HTN	Upper	26,27	120	–	None	EU	2011-03-31	SCC	Well	II	Ab	Xeno	HA coated	Sc	PFM	P/inlay	Gold
10	M	59	Moderate	–	n/s	Lower	34,35	–	–	None	EU	2011-04-14	SCC	Well	I	Ab	-	RBM	C	PFM	P	PFM
11	M	63	Moderate	–	Drug allergy	Lower	45,46,47	60	–	None	EU	2011-10-11	SCC	Well	IV	Pr	-	SLA	Sc	PFM	P/implant	PFM
12	F	64	Moderate	–	n/s	Upper	16	17	–	n.c	EU	2012-03-16	SCC	Well	IV	Pr	Xeno	HA blast and acid wash	C	PFM	P/implant	PFM
13	F	76	Poor	–	HTN, TB Hx, HL	Lower	45,46,47	100, 74	OLP	None	E	2012-08-13	SCC	Well	I	Ab	Xeno	Ti-unite	C	PFM	P	PFM
14	M	58	Moderate	–	n/s	Lower	36,37	58	Previous SCC	n.c	EU	2012-12-24	SCC	Well	IV	Pr	Syn	RBM	Sc	Gold	P/implant	PFM
15	M	63	Moderate	S	GC, DM	Upper	26,27	24	–	n.c	E	2013-03-12	SCC	Poor	II	Ab	Xeno	HA coated	C	PFM	P/inlay	Gold
16	F	58	Moderate	–	DM	Lower	35,36	84	–	None	E	2013-04-15	SCC	Well	IV	Pr	Auto	SLA	C	PFM	None	–
17	F	40	Poor	–	n/s	Upper	23,25	59	Candidiasis	None	E	2013-04-18	SCC	Well	II	Ab	Xeno	Ti-unite (Ti-O2)	Sc	Gold	P	PFM
18	M	71	Moderate	–	HTN	Lower	36,37	79	–	None	EU	2014-04-22	SCC	Well	IV	Pr	Xeno	SLA	C	PFM	P	Gold
19	M	51	Moderate	–	n/s	Upper	24,26, 27	–	–	n.c	E	2010-12-17	Melanoma	Well	I	Ab	-	SLA	C	PFM	P	Gold
20	M	63	Moderate	–	HTN	Upper	26	–	–	None	E	2017-07-24	SCC	Well	IV	Pr	-	TiUnite	C	Gold	P	PFM
21	M	70	Poor	–	DM	Lower	45,46,47	–	Previous SCC	None	EU	2017-08-14 2018-01-15	SCC	Well	IV	Pr	Allo	TiUnite	C	PFM	P	PFM

No.: number; OH: oral hygiene; S/A: smoking or alcohol; PMH: past medical history; IS: implant site; PC: precancerous lesion; HPV: human papilloma virus detected through Microarray; CA: clinical appearance; Op.: operation; Dx: diagnosis; HF: histopathologic finding; pStage: pathologic staging; BI: bone involvement; BG: bone graft history; ImpS: implant surface treatment; RS: retention; PM: prosthesis material; OccP: occluding prosthesis presence; OccPM: occluding prosthesis material
M: male; F: female; n/s: non-specific; HTN: hypertension; LC: liver cirrhosis; Mx: medications; TB Hx: pulmonary tuberculosis history; HL: hyperlipidemia; GC: gastric cancer; DM: diabetes mellitus; SCC: squamous cell carcinoma; OLP: oral lichen planus; n.c: not checked; E: exophytic; U: ulcerated; EU: exophytic + ulcerated; VC: verrucous carcinoma; Pr: presence; Ab: absence; Auto: autogenous bone graft; Allo: allogenic bone graft; Xeno: xenogenic bone graft; Syn: synthetic bone graft; SLA: sand blasted and acid-etched; RBM: resorbable blast media; TPS: titanium plasma spray; HA: hydroxyapatite; Sc: screw type; C: cemented type; P: prosthesis; PFM: porcelain fused to metal prosthesis

Back to article page